Cargando…
Newly Diagnosed Primary Open-Angle Glaucoma Randomized to 2 Trabecular Bypass Stents or Prostaglandin: Outcomes Through 36 Months
PURPOSE: To examine outcomes through 36 months in phakic eyes with newly diagnosed primary open-angle glaucoma (POAG) naïve to therapy randomized to treatment with two trabecular micro-bypass stents or topical prostaglandin. METHODS: Subjects with POAG naïve to therapy, with intraocular pressure (IO...
Autores principales: | Vold, Steven D., Voskanyan, Lilit, Tetz, Manfred, Auffarth, Gerd, Masood, Imran, Au, Leon, Ahmed, Iqbal Ike K., Saheb, Hady |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5125126/ https://www.ncbi.nlm.nih.gov/pubmed/27619225 http://dx.doi.org/10.1007/s40123-016-0065-3 |
Ejemplares similares
-
Erratum to: Newly Diagnosed Primary Open-Angle Glaucoma Randomized to 2 Trabecular Bypass Stents or Prostaglandin: Outcomes Through 36 Months
por: Vold, Steven D., et al.
Publicado: (2016) -
iStent trabecular micro-bypass stent for open-angle glaucoma
por: Le, Kim, et al.
Publicado: (2014) -
Prospective Evaluation of Two iStent(®) Trabecular Stents, One iStent Supra(®) Suprachoroidal Stent, and Postoperative Prostaglandin in Refractory Glaucoma: 4-year Outcomes
por: Myers, Jonathan S., et al.
Publicado: (2018) -
Efficacy and Adverse Event Profile of the iStent and iStent Inject Trabecular Micro-bypass for Open-angle Glaucoma: A Meta-analysis
por: Popovic, Marko, et al.
Publicado: (2018) -
Second-Generation Trabecular Micro-Bypass Stents as Standalone Treatment for Glaucoma: A 36-Month Prospective Study
por: Hengerer, Fritz H., et al.
Publicado: (2019)